Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Acta Oncologica (Stockholm, Sweden)|April 2, 2015
Magnetic resonance imaging of the carotid artery in long-term head and neck cancer survivors treated with radiotherapyJoyce Wilbers, Frederick J A Meijer, Arnoud C Kappelle, et al.
BMC Cancer|October 11, 2012
Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neckHanneke Stegeman, Johannes H Kaanders, Deric L Wheeler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 12, 2016
Quality-of-life after radiotherapy for advanced laryngeal cancer: Results of a phase III trial of the Dutch Head and Neck SocietyGeert O Janssens, Johannes A Langendijk, Chris H Terhaard, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 9, 2011
Parametric mapping of immunohistochemically stained tissue sections; a method to quantify the colocalization of tumor markersSaskia E Rademakers, Paul F Rijken, Wenny J Peeters, et al.
Head & Neck|December 19, 2013
Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: results of the accelerated radiotherapy with carbogen breathing and nicotinamide phase III randomized trialSaskia E Rademakers, Ilse J Hoogsteen, Paul F Rijken, et al.
Neuro-Oncology Practice|August 7, 2019
Cognitive function, depression, fatigue and quality of life among long-term survivors of head and neck cancerJoyce Wilbers, Arnoud C Kappelle, Laura Versteeg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2014
Progression of carotid intima media thickness after radiotherapy: a long-term prospective cohort studyJoyce Wilbers, Lucille D Dorresteijn, Roy Haast, et al.
Cancers|April 20, 2019
Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study)Chantal M Driessen, Janneke C Ham, Maroeska Te Loo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2014
Improved recurrence-free survival with ARCON for anemic patients with laryngeal cancerGeert O Janssens, Saskia E Rademakers, Chris H Terhaard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2014
Computed tomography-based tumour volume as a predictor of outcome in laryngeal cancer: results of the phase 3 ARCON trialGeert O Janssens, Liselotte W van Bockel, Patricia A Doornaert, et al.
Pageof 4